Increased expression of CD80 and CD86 in in vitro-infected CD3+ cells producing cytoplasmic HIV type 1 p24

AIDS Research and Human Retroviruses

Volumn 15, Issue 2, 1999, Pages 173-181

  Jason, Janine ^a   Inge, K Leigh ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; PHYTOHEMAGGLUTININ;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD86; BIOLOGICAL MARKERS; FLOW CYTOMETRY; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV SERONEGATIVITY; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; RECEPTORS, INTERLEUKIN-2;

EID: 0033585419     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311592     Document Type: Article

References (44)

1. Cory JM, Ohlsson-Wilhelm BM, Brock EJ, Sheaffer NA, Steck ME, Eyster ME, and Rapp F: Detection of human immunodeficiency virus-infected lymphoid cells at low frequency by flow cytometry. J Immunol Methods 1987;105:71-78.
2. Cory JM, Ohlsson-Wilhelm BM, Steck ME, Smithgall MD, Rozday V, Eyster ME, and Rapp F: Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units. AIDS Res Hum Retroviruses 1989;5:97-106.
3. McSharry JJ, Costantino R, Robbiano E, Echols R, Stevens R, and Lehman JM: Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry. J Clin Microbiol 1990;28:724-733.
4. Ohlsson-Wilhelm BM, Cory JM, Kessler HA, Eyster ME, Rapp F, and Landay A: Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: A flow cytometric measure of HIV infection. J Infect Dis 1990;162:1016-1024.
5. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
6. Patterson BK, Till M, Otto P, Goolsby C, Furtado MR, McBride LJ, and Wolinsky SM: Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993;260:976-979.
7. Jason J and Larned J: Single-cell cytokine profiles in normal humans: Comparison of flow cytometric reagents and stimulation protocols. J Immunol Methods 1997;207:13-22.
8. Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, and Gallo RC: Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T cell depletion in AIDS. Science 1986;231:850-853.
9. Stevenson M, Stanwick TL, Dempsey MP, and Lamonica CA: HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990;9:1551-1560.
10. McDougal JS, Mawle A, Cort SP, Nicholson JKA, Cross GD, Scheppler-Campbell JA, Hicks D, and Sligh J: Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol 1985;135:3151-3162.
11. Tang S, Patterson B, and Levy JA: Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation. J Virol 1995;69:5659-5665.
12. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Hasilip A, and Chen ISY: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61:213-222.
13. Jason J and Inge KL: The effects of mitogens, IL-2, and anti-CD3 antibody on the T cell receptor Vβ repertoire. Scand J Immunol 1996;43:652-661.
14. Bjorndal A, Deng H, Jansson M, Fiore JF, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, and Fenyö EM: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71:7478-7487.
15. Mahalingam M, Pozniak A, McManus TJ, Vergani D, and Peakman M: Cell cycling in HIV infection: Analysis of in vivo activated lymphocytes. Clin Exp Immunol 1995;102:481-486.
16. Saifuddin M, Saarloos M-N, and Spear G: Both HIV and HTLV virions incorporate T cell activation markers IL-2 receptor and HLA-DR. In: 3rd Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 28-February 1, 1996. [Abstract 80]
17. Giorgi JV, Boumsell L, and Autran B: Reactivity of workshop T cell section MAb with circulating CD4+ and CD8+ T cells in HIV disease and following in vitro activation. In: Leukocyte Typing V: White Cell Differentiation Antigens (Schlossman S, Boumsell L, Gilks W, et al., eds.), Vol. 1. Oxford University Press, Oxford, 1995, pp. 446-461.
18. Roos MTL, Lange JMA, deGoede REY, Coutinho RA, Schellekens PTA, Miedema F, and Tersmette M: Virus phenotype and immune response in primary human immunodeficiency virus type 1 (HIV-1) infection. J Infect Dis 1992;165:427-432.
19. Ferbas J, Kaplan AH, Hausner MA, Hultin LE, Matud JL, Liu Z, Panicali DL, Nerng-Ho H, Detels R, and Giorgi JV: Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329-339.
20. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, and Egeland T: Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: Functional and clinical correlations. J Infect Dis 1994;169:730-738.
21. Dudhane A, Conti B, Orlikowsky T, Wang ZQ, Mangla N, Gupta A, Wormser GP, and Hoffmann MK: Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses 1996;12:885-892.
22. Landay AL, Mackewicz CE, and Levy JA: An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol 1993;69:106-116.
23. June CH, Ledbetter JA, Linsley PS, and Thompson CB: Role of the CD28 receptor in T cell activation. Immunol Today 1989;11:211-216.
24. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, and Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-730.
25. Fernández-Ruiz E, Somoza C, Sánchez-Madrid F, and Lanier LL: CD28/CTLA-4 ligands: The gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23. Eur J Immunol 1995;25:1453-1456.
26. Inobe M, Aoki N, Linsley PS, Ledbetter JA, Abe R, Murakami M, and Uede T: The role of the B7-1a molecule, an alternatively splice form of murine B7-1 (CD80), on T cell activation. J Immunol 1996;157:582-588.
27. Gimmi CD, Freeman GJ, Gribben JG, Gray G, and Nadler LM: Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993;90:6586-6590.
28. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, and Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707-718.
29. Petro TM, Chen SS, and Panther RB: Effect of CD80 and CD86 on T cell cytokine production. Immunol Invest 1995;24:965-976.
30. Chen C and Nabavi N: In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994;1:147-154.
31. Tao X, Constant S, Jorritsma P, and Bottomly K: Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J Immunol 1997;159:5956-5963.
32. Vallé AP, Garrone P, Yssel H, Bonnefoy J-Y, Freedman AS, Freeman G, Nadler LM, and Banchereau J: mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-I-transformed T cells. Immunology 1990;69:531-535.
33. Lal RB, Rudolph DL, Dezzutti CS, Linsley PS, and Prince HE: Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands. J Immunol 1996;157:1288-1296.
34. Freeman GJ, Lombard DB, Gimmi CD, Brod SA, Lee K, Laning JC, Hafler DA, Dorf ME, Gray GS, Reiser H, June CH, Thompson CB, and Nadler LM: CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol 1992;149:3795-3801.
35. Haffar OK, Smithgall MD, Bradshaw J, Brady B, Damle NK, and Linsley PS; Costimulation of T cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. Proc Natl Acad Sci USA 1993;90:11094-11098.
36. Hirokawa M, Kitabayashi A, Kuroki J, and Miura AB: Signal transduction by B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T cell receptor/CD3. Immunology 1995;86:155-161.
37. Ghiotto-Ragueneau M, Battifora M, Trunch A, Waterfield MD, and Olive D: Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: Phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur J Immunol 1996;26:34-41.
38. Groux H, Torpier G, Monté D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
39. Noel PJ, Boise LH, Green JM, and Thompson CB: CD28 costimulation prevents cell death during primary T cell activation. J Immunol 1996;157:636-642.
40. Clerici M and Shearer GM: A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
41. Romagnani S, Maggi E, and del Prete G: An alternative view of the Th1/Th2 shift hypothesis in HIV infection. AIDS Res Hum Retroviruses 1994;10:3-9.
42. Corry DB, Reiner SL, Linsley PS, and Locksley RM: Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J Immunol 1994;153:4142-4148.
43. King CL, Stupi RJ, Craighead N, June CH, and Thyphronitis G: CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol 1995;25:587-595.
44. Creery WD, Diaz-Mitoma F, Filion L, and Kumar A: Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol 1996;26:1273-1277.